<qa>  What is the name of the battery that could be used to evaluate new drugs for AlzheimersThe early assessment of new drugs for Alzheimers disease remains difficult because of the lack of predictive end-point. The use of a battery including different parameters could improve this early development of new drugs. Nevertheless, the interest of such a battery should previously be validated with the yet marketed AD drugs. 